Evidence map›Paper›PMID 38274796›Full record

ArticleFrontiers in immunology2023

Circulating microbiome analysis in patients with perioperative anaphylaxis.

Luc de Chaisemartin, Dragos Ciocan, Aurélie Gouel-Chéron, Vanessa Granger, Dan Longrois, Philippe Montravers, Anne-Marie Cassard, Sylvie Chollet-Martin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Luc de ChaisemartinAP-HP, Immunology Department, Bichat Hospital, Paris, France.
Dragos CiocanUniversité Paris-Saclay, Inserm, Inflammation, Microbiome, Immunosurveillance, Orsay, France.
Aurélie Gouel-ChéronDépartement d'Anesthésie-Réanimation, CHU Bichat-Claude Bernard, DMU PARABOL, AP-HP.Nord, AP-HP, Paris, France.
Vanessa GrangerAP-HP, Immunology Department, Bichat Hospital, Paris, France.
Dan LongroisUniversité de Paris, FHU PROMICE, Paris, France.
Philippe MontraversDépartement d'Anesthésie-Réanimation, CHU Bichat-Claude Bernard, DMU PARABOL, AP-HP.Nord, AP-HP, Paris, France.
Anne-Marie CassardUniversité Paris-Saclay, Inserm, Inflammation, Microbiome, Immunosurveillance, Orsay, France.
Sylvie Chollet-MartinAP-HP, Immunology Department, Bichat Hospital, Paris, France.
Inserm · FRUniversité Claude Bernard Lyon 1 · FRInstitut thématique Immunologie, inflammation, infectiologie et microbiologie · FRNational Institutes of Health · USUniversité Paris-Saclay · FRUniversité Sorbonne Paris Nord · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Perioperative anaphylaxis is a rare and acute systemic manifestation of drug-induced hypersensitivity reactions that occurs following anesthesia induction; the two main classes of drugs responsible for these reactions being neuromuscular blocking agents (NMBA) and antibiotics. The sensitization mechanisms to the drugs are not precisely known, and few risk factors have been described. A growing body of evidence underlines a link between occurrence of allergy and microbiota composition. However, no data exist on microbiota in perioperative anaphylaxis. The aim of this study was to compare circulating microbiota richness and composition between perioperative anaphylaxis patients and matched controls. Methods: Circulating 16s rDNA was quantified and sequenced in serum samples from 20 individuals with fully characterized IgE-mediated NMBA-related anaphylaxis and 20 controls matched on sex, age, NMBA received, type of surgery and infectious status. Microbiota composition was analyzed with a published bioinformatic pipeline and links with patients clinical and biological data investigated. Results: Analysis of microbiota diversity showed that anaphylaxis patients seem to have a richer circulating microbiota than controls, but no major differences of composition could be detected with global diversity indexes. Pairwise comparison showed a difference in relative abundance between patients and controls for Conclusion: We did not find a global difference in terms of microbiota composition between anaphylaxis patient and controls. However, several taxa were associated with anaphylaxis patients and with their biological data. These findings must be further confirmed in different settings to broaden our understanding of drug anaphylaxis pathophysiology and identify predisposition markers.

Indexed as

AnaphylaxisDrug HypersensitivityNeuromuscular Blocking AgentsHumansImmunoglobulin ERisk FactorsTryptasesImmunoglobulin ENeuromuscular Blocking AgentsTryptasesIgE-mediated hypersensitivitymicrobiomeneuromuscular blocking agentsperioperative anaphylaxistryptase

Identifiers

PMID38274796
PMCPMC10808669
OpenAlexW4390744701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.